Advanced in Myeloproliferative Neoplasms (MPN)

Nadja Jaekel

Halle, NI, DE 
Advanced in Myeloproliferative Neoplasms (MPN)
Halle, NI, DE 
OverviewLocationsClinical Research

Overview

Nadja Jaekel practices in Halle, Germany. Ms. Jaekel is rated as an Advanced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Myelofibrosis, Systemic Mastocytosis, Splenomegaly, and Mast Cell Activation Syndrome (MCAS).

Her clinical research consists of co-authoring 29 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Myeloproliferative Neoplasms (MPN).

Gender
Female

Locations

Halle, NI 06120, Germany
Other Locations
Frankfurt Am Main, HE, Germany
Onkologie und Hämostaseologie
Leipzig, SN, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Ruxolitinib Versus Allogeneic Stem Cell Transplantation for Patients With Myelofibrosis According to Donor Availability: A Prospective Phase II Trial (MMM 02 Study)
Ruxolitinib Versus Allogeneic Stem Cell Transplantation for Patients With Myelofibrosis According to Donor Availability: A Prospective Phase II Trial (MMM 02 Study)
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2025
Intervention Type: Drug, Procedure
Study Drug: Ruxolitinib continuous therapy
Study Phase: Phase 2

29 Total Publications

Long-Term Immune Response to SARS-CoV-2 Vaccination in Hematologic Malignancies: An Update of the ImV-HOng Trial of the East German Study Group for Hematology and Oncology.
Long-Term Immune Response to SARS-CoV-2 Vaccination in Hematologic Malignancies: An Update of the ImV-HOng Trial of the East German Study Group for Hematology and Oncology.
Journal: Cancers
Published: July 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Jaekel's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile